Navigation Links
Medarex Announces 2008 Fourth Quarter and Year End Financial Results
Date:2/25/2009

A regulatory filing for market approval in the U.S. has also been submitted.
  • Announcing the receipt of other milestone payments from licensing partners, NovoNordisk and Pfizer, Inc., for the submission of two separate investigational new drug (IND) filings to the U.S. Food and Drug Administration (FDA) in March 2008 and September 2008, respectively.
  • Reaching strong proof-of-concept Phase 2 data in November 2008 for the C. difficile program (MDX-066 and MDX-1388), which demonstrated a 70 percent reduction in disease recurrence when added to standard of care antibiotics as compared to placebo treatment.
  • Advancing our pipeline with the initiation of Phase 2 trials for the MDX-1100 anti-IP10 antibody for the treatment of ulcerative colitis and rheumatoid arthritis, announced in May 2008, and a Phase 2 trial for the MEDI-545 anti-interferon-alpha antibody being developed by MedImmune Inc., announced in August 2008.
  • Advancing our pipeline with the initiation of Phase 1 oncology trials for the MDX-1411 anti-CD70 antibody for the treatment of renal cancer and lymphoma and a Phase 1b trial for the MDX-1106 anti-PD-1 antibody for the treatment of solid tumors in April 2008 and November 2008, respectively.
  • Expanding our oncology pipeline with two new IND filings with the FDA, one for the MDX-1105 anti-PD-L1 antibody and one for the MDX-1203 anti-CD70 program, Medarex's first antibody-drug conjugate, in August 2008 and December 2008, respectively.
  • Strengthening our cash resources in February 2008 with the addition of approximately $151.8 million through the sale of 2.5 million shares of Genmab A/S common stock, reducing our ownership in Genmab to approximately 5.1 percent.
  • Non-GAAP Financial Measurements

    This press release and the accompanying tables include non-GAAP financial measures. Please see the section of the accompanying
    '/>"/>

    SOURCE Medarex, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine news :

    1. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
    2. Medarex to Present at the JPMorgan Small/Mid Cap Conference
    3. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
    4. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
    5. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
    6. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
    7. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
    8. Medarex Announces 2008 First Quarter Financial Results
    9. Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
    10. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
    11. Medarex Reviews Recent Highlights and Outlook for 2009
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/20/2014)... (PRWEB) October 20, 2014 ASCNYC ... organization that helps New Yorkers living with HIV/AIDS ... toward health, housing, recovery and self-sufficiency. Each year, ... the local community through their tireless efforts. , ... Marc Shapses , has been selected as this ...
    (Date:10/20/2014)... Ga. (PRWEB) October 20, 2014 ... and relationship-marketing firm, announced today that William H. ... named the 2014 ISE® Luminary Leadership Award winner. ... the achievements of an outstanding leader and industry ... and contributions in advancing the information security industry. ...
    (Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive ... a platform to think outside the bra. She doesn’t try ... to raise awareness about women’s other lady parts. , "We ... say the color pink and everybody knows what you’re talking ... that it has not been won when it comes to ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 My Clients ... management software application. The new module enables easy ... receive full life-cycle quality care. , This application allows ... within their practice, attach a to-do item to a ... and even set up reoccurring reminders for follow-ups. ...
    (Date:10/20/2014)... October 20, 2014 AttorneyOne.com, a recognized authority ... information from the FDA on Sit and Slim II ... not to purchase or use Sit and Slim II because ... II is promoted as weight loss product on various websites ... the market in 2010 for safety reasons, can significantly increase ...
    Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2
    ... study finds , , WEDNESDAY, Aug. 29 (HealthDay News) -- ... natural menopause increases the risk of both dementia and ... giving hormone-replacement therapy at least until the age of ... Mayo Clinic researchers. , "It,s the first study that ...
    ... suggests , , WEDNESDAY, Aug. 29 (HealthDay News) -- Can spotting ... simple as seeing which arm she uses to carry her ... cradle their baby on their right side may be struggling ... some levels of stress during the first weeks and months ...
    ... rates better than education or incomes, according to a ... this week by the journal Social Science and Medicine. ... homes, UW researchers found, obesity rates in a given ... based on analyses of responses to a telephone survey ...
    ... In a report that is among the first to ... C viruses in Afghanistan, a researcher from the University ... concerns that increasing injection drug use and accompanying high-risk ... , Our findings suggest that interventions to ...
    ... chances of being overweight, obese by age 7 were ... News) -- When women develop diabetes during pregnancy and ... of childhood obesity, but new research suggests that treatment ... the doubling of the risk of obesity can be ...
    ... by continued abuse, study finds , TUESDAY, Aug. 28 ... of the liver have more brain function impairment than ... gene expression in the frontal cortex of the brains ... cirrhosis. , "We found that the levels of many ...
    Cached Medicine News:Health News:Removing Ovaries Before Menopause Leads to Memory, Movement Troubles 2Health News:Removing Ovaries Before Menopause Leads to Memory, Movement Troubles 3Health News:Stressed-Out Moms Carry Babies on the Right 2Health News:ZIP codes and property values predict obesity rates 2Health News:High-risk behaviors could lead to HIV epidemic in Afghanistan 2Health News:High-risk behaviors could lead to HIV epidemic in Afghanistan 3Health News:Treating Diabetes During Pregnancy Could Lead to Thinner Kids 2Health News:Alcoholics With Cirrhosis Have More Brain Damage 2
    (Date:10/20/2014)... Norgine B.V. today announced that ... bowel preparation, NER1006, presented at the 79 th ... (ACG), Philadelphia, PA , has met ... co-primary endpoint of cleansing success. The study demonstrated high ... in screening colonoscopy patients. [1] ...
    (Date:10/19/2014)... 19, 2014 Große Pharmafirmen ... Das Problem dabei ist, dass große Pharmafirmen nicht ... zu teilen. Es war deshalb nicht ... uns umso mehr, dass es uns gelungen ist! ... Kühlketten aufzuschreiben - mit einem Vorbehalt - einige ...
    (Date:10/17/2014)... OAKS, Calif. , Oct. 17, 2014  Amgen ... of R. Sanders Williams , M.D., president of ... Mahley Distinguished Professor.  "We are pleased ... Amgen Board," said Robert A. Bradway , chairman ... and distinguished experience in academic medicine and his direct ...
    Breaking Medicine Technology:Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2Vergleichsbericht zu Pharma-Kühlketten und CRT 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3
    ... Topcon combines the best 32-bit software package ... hardware offerings to bring you a fast ... high-resolution package takes advantage of the Compaq ... latest graphics capture technology and a formidable ...
    ... The new TM-1 is a ... that provides precise measurement of ... transmission for all types of ... to easily connect with a ...
    Inquire...
    ... This power table has everything that ... instrumentation. The new AIT-15 offers 20 mm ... convenience outlets, and locking castors to secure ... work perfectly for most any application. Use ...
    Medicine Products: